|

0.9% sodium chloride Clinical Trials

3 actively recruiting trials

No change since May 2026

Also known as: normal saline, placebo

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • The George Institute1
  • Sirius Therapeutics Co., Ltd.1
  • Beijing Anzhen Hospital1

Indications

  • Heart Disease2
  • Coronary Artery Disease (CAD)1
  • Atrial Fibrillation (AF)1
  • Diabetic Ketoacidosis1
  • Acute Kidney Injury1

Other3 trials

A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Phase 2
Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis
Phase 3
Peri-procedural Hydration to Prevent Acute Kidney Injury After Pulsed Field Ablation for Atrial Fibrillation
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.